by admin-post | Nov 24, 2020 | Uncategorized
The FDA has published a draft guidance containing Additional Q&As on Biosimilar Development and the BPCI Act, which after finalization, will be added as a revision to final Q&As on biosimilar development. Four Q&As (I.25 to I.28) have been added to...
by admin-post | Nov 20, 2020 | Uncategorized
About CBCC Global Research At CBCC Global Research, we are accelerating medical therapy development by providing high quality, affordable and innovative solutions. We provide strategic solutions for all phases of clinical trials through efficient delivery of services...
by admin-post | Nov 12, 2020 | Uncategorized
CBCC Global Research launches spirometry services for respiratory clinical trials. Being the most experienced core lab in India, CBCC Global Research is proud to introduce ‘SpiroClin’- purpose-built software for over-reading spirometry data. About CBCC Global Research...